1. Vakhlyueva O.G. Kliniko-diagnosticheskie kriterii pishchevoda Barretta i adenokartsinomy pishchevoda. Byulleten' meditsinskikh internet-konferentsii. 2013; 3 (3): 517−519.
2. Ahmad J., Arthur K., Maxwell P., Kennedy A., Johnston B.T., Murray L., McManus D.T. A cross sectional study of p504s, CD133, and Twist expression in the esophageal metaplasia dysplasia adenocarcinoma sequence. Dis. Esophagus. 2015; 28 (3): 276−282. DOI: 10.1111/dote.12181.
3. Pirogov S.S., Karseladze A.I. Molekulyarno-geneticheskie issledovaniya v diagnostike i otsenke neoplasticheskoi progressii pishchevoda Barretta (obzor). Sibirskii onkologicheskii zhurnal. 2008; 1: 85−94.
4. Ter-Ovanesov M.D. Pishchevod Barretta: etiologiya, patogenez, sovremennye podkhody k lecheniyu (obzor). Meditsinskii al'manakh. 2011; 5: 41−48.
5. Zali M.R., Zadeh-Esmaeel M.M., Rezaei-Tavirani M., Tabatabaei S.E., Ahmadi A.N. Barrett’s esophagus transits to a cancer condition via potential biomarkers. Gastroenterol. Hepatol. Bed. Bench. 2018; 11 (Suppl. 1): S80−S84.